New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

Five percent to 9% of pancreatic ductal adenocarcinomas (PDACs) develop in patients with a germline BRCA1/2 or PALB2 (g BRCA/PALB2 +) mutation. Phase IB data from a trial that used cisplatin, ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory and infectious diseases, today announced detailed results ...

The multicenter study is led by National Principal Investigator Dr. Aravinda Nanjundappa, MD, an Interventional Cardiologist at the Cleveland Clinic in Cleveland, Ohio. The first patient procedure ...

Lateral transiliac sacroiliac joint fusion by interventional pain management physicians using a threaded implant reduced pain and improved disability.

"Multicenter clinical study supports safety of deep general anesthesia." ScienceDaily. ScienceDaily, 10 June 2024. <www.sciencedaily.com / releases / 2024 / 06 / 240610140150.htm>.

Our multicenter, randomized, double-blind study of 600 infants with acute, moderate-to-severe bronchiolitis in the emergency department showed no significant reduction in hospital admissions or ...

Adults with pediatric-onset bronchiectasis have increased disease severity compared with those with adult-onset bronchiectasis.